PMC:7445716 / 62726-63321 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T505","span":{"begin":49,"end":56},"obj":"Body_part"},{"id":"T506","span":{"begin":77,"end":84},"obj":"Body_part"},{"id":"T507","span":{"begin":89,"end":93},"obj":"Body_part"},{"id":"T508","span":{"begin":108,"end":111},"obj":"Body_part"},{"id":"T509","span":{"begin":241,"end":247},"obj":"Body_part"},{"id":"T510","span":{"begin":300,"end":326},"obj":"Body_part"}],"attributes":[{"id":"A505","pred":"fma_id","subj":"T505","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A506","pred":"fma_id","subj":"T506","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A507","pred":"fma_id","subj":"T507","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A508","pred":"fma_id","subj":"T508","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A509","pred":"fma_id","subj":"T509","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A510","pred":"fma_id","subj":"T510","obj":"http://purl.org/sig/ont/fma/fma9906"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T195","span":{"begin":300,"end":326},"obj":"Body_part"},{"id":"T196","span":{"begin":312,"end":326},"obj":"Body_part"}],"attributes":[{"id":"A195","pred":"uberon_id","subj":"T195","obj":"http://purl.obolibrary.org/obo/UBERON_0000013"},{"id":"A196","pred":"uberon_id","subj":"T196","obj":"http://purl.obolibrary.org/obo/UBERON_0001016"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T548","span":{"begin":16,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T549","span":{"begin":89,"end":93},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T550","span":{"begin":241,"end":247},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T551","span":{"begin":400,"end":401},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T552","span":{"begin":490,"end":495},"obj":"http://www.ebi.ac.uk/efo/EFO_0000876"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T52103","span":{"begin":27,"end":29},"obj":"Chemical"},{"id":"T40243","span":{"begin":30,"end":32},"obj":"Chemical"},{"id":"T42541","span":{"begin":49,"end":56},"obj":"Chemical"},{"id":"T85765","span":{"begin":77,"end":84},"obj":"Chemical"},{"id":"T69099","span":{"begin":212,"end":214},"obj":"Chemical"},{"id":"T40436","span":{"begin":279,"end":288},"obj":"Chemical"},{"id":"T34758","span":{"begin":362,"end":370},"obj":"Chemical"},{"id":"T56611","span":{"begin":585,"end":594},"obj":"Chemical"}],"attributes":[{"id":"A80815","pred":"chebi_id","subj":"T52103","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A89628","pred":"chebi_id","subj":"T40243","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A93875","pred":"chebi_id","subj":"T42541","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A91305","pred":"chebi_id","subj":"T85765","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A48019","pred":"chebi_id","subj":"T85765","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A30832","pred":"chebi_id","subj":"T69099","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A85151","pred":"chebi_id","subj":"T40436","obj":"http://purl.obolibrary.org/obo/CHEBI_6343"},{"id":"A84545","pred":"chebi_id","subj":"T34758","obj":"http://purl.obolibrary.org/obo/CHEBI_16189"},{"id":"A27612","pred":"chebi_id","subj":"T56611","obj":"http://purl.obolibrary.org/obo/CHEBI_6343"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T22","span":{"begin":248,"end":256},"obj":"http://purl.obolibrary.org/obo/GO_0015297"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"LitCovid-PubTator","denotations":[{"id":"854","span":{"begin":76,"end":83},"obj":"Chemical"},{"id":"949","span":{"begin":433,"end":445},"obj":"Disease"}],"attributes":[{"id":"A854","pred":"tao:has_database_id","subj":"854","obj":"MESH:D005947"},{"id":"A949","pred":"tao:has_database_id","subj":"949","obj":"MESH:D012021"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"LitCovid-sentences","denotations":[{"id":"T367","span":{"begin":0,"end":595},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T727","span":{"begin":166,"end":179},"obj":"Phenotype"},{"id":"T728","span":{"begin":434,"end":446},"obj":"Phenotype"},{"id":"T729","span":{"begin":512,"end":526},"obj":"Phenotype"}],"attributes":[{"id":"A727","pred":"hp_id","subj":"T727","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A728","pred":"hp_id","subj":"T728","obj":"http://purl.obolibrary.org/obo/HP_0001265"},{"id":"A729","pred":"hp_id","subj":"T729","obj":"http://purl.obolibrary.org/obo/HP_0007209"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T821","span":{"begin":77,"end":84},"obj":"CHEBI:17234;CHEBI:17234"},{"id":"T822","span":{"begin":112,"end":117},"obj":"NCBITaxon:10239"},{"id":"T823","span":{"begin":184,"end":190},"obj":"GO:0030424"},{"id":"T824","span":{"begin":241,"end":247},"obj":"UBERON:0001969"},{"id":"T825","span":{"begin":279,"end":288},"obj":"CHEBI:6343;CHEBI:6343"},{"id":"T826","span":{"begin":300,"end":326},"obj":"UBERON:0000013"},{"id":"T827","span":{"begin":362,"end":370},"obj":"CHEBI:32168;CHEBI:32168"},{"id":"T828","span":{"begin":490,"end":495},"obj":"UBERON:0002101"},{"id":"T829","span":{"begin":512,"end":518},"obj":"UBERON:0001456"},{"id":"T830","span":{"begin":569,"end":579},"obj":"GO:0065007"},{"id":"T831","span":{"begin":585,"end":594},"obj":"CHEBI:6343;CHEBI:6343"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}

{"project":"2_test","denotations":[{"id":"32840686-32618839-63205790","span":{"begin":15,"end":17},"obj":"32618839"}],"text":"Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,"}